InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Dorling Janet. Director active across 1 company, notably CymaBay Therapeutics, Inc.. Cumulatively, 4 filings have been published. Activity tracked since 10 November 2023. The latest transaction was filed on 12 February 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Dorling Janet is a declarant and a director of CymaBay Therapeutics, Inc. (XNAS). She has 4 filings in total, and across the sampled recent filings from 2023-11-14 to 2024-02-14, the most frequent transaction type is option exercise.